Skip to main content

Market access strategy

Our team has experience in advising companies on the optimal market access strategy. We assist companies in market access trajectories by developing reimbursement dossiers in line with European and international HTA guidelines.

We support our clients

We support our clients with our tailor-made advice on reimbursement paths for new technologies in a fast-changing and complex setting of reimbursement policy. Our consultants are experts in providing extensive and comprehensive market access scans to guarantee optimal market access to new products in any therapeutic area. We ensure an exhaustive and positive experience by proving friendly and responsive customer service and by involving experienced partners and clinical experts in our decisions.

Related cases:

These noteworthy case studies have been selected to show our capabilities in market access strategies

Stakeholder Report for Market Access Challenges and Solutions in CGT

Asc Academics created a stakeholder report to highlight the views of all stakeholders on the challenges and proposed solutions for improving market access for Cell and Gene Therapy (CGT) in the Netherlands.

Read the case